未登录

M

Michelandrea De Cesare

fondazione irccs istituto nazionale tumori milan

H指数:34

被引数:3,624

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma

CANCER GENE THERAPY

IF5

2022-03-296

OAAI

Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells

BIOCHEMICAL PHARMACOLOGY

IF5.6

2022-03-0110

PRE

Synthesis and Evaluation of the Tumor Cell Growth Inhibitory Potential of New Putative HSP90 Inhibitors

IF4.6

2018-02-1316

OAAI

Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases

IF10.1

2018-02-0127

PREAI

FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models

BIOCHEMICAL PHARMACOLOGY

IF5.6

2018-01-0142

PREAI

Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat

肝素酶抑制剂roneparstat的微环境调节和增强抗淋巴瘤治疗

HEMATOLOGICAL ONCOLOGY

IF3.9

2017-07-2114

PREAI

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: Persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Role of FOXO1 in response of ovarian carcinoma cells to the XPO1/CRM1 inhibitor KPT-330/selinexor in combination with cisplatin

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on Tubuvaline

CHEMISTRY-A EUROPEAN JOURNAL

IF3.7

2017-04-1213

OAAI

1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer Treatment

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2017-03-2051

OAAI

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2017-01-1838

OAAI

3-Arylidene-N-hydroxyoxindoles: A New Class of Compounds Endowed with Antitumor Activity

IF3.4

2016-06-177

OAAI

Biphenyl-4-yl-acrylohydroxamic acids: Identification of a novel indolyl-substituted HDAC inhibitor with antitumor activity

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2016-04-0120

OAAI

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2016-01-2517

OAAI

Antitumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin

CANCER RESEARCH

IF16.6

2015-08-010

PRE

Combination of metronomic gimatecan and CpG-oligodeoxynucleotides against an orthotopic pancreatic cancer xenograft

CANCER BIOLOGY & THERAPY

IF4.6

2014-10-2711

OAAI

A New Avenue toward Androgen Receptor Pan-antagonists: C2 Sterically Hindered Substitution of Hydroxy-propanamides

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2014-08-2864

PREAI

YM155 sensitizes triple- negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2014-06-0535

OAAI

Influence of the adamantyl moiety on the activity of biphenylacrylohydroxarnic acid-based HDAC inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2014-05-0128

OAAI

Improved Apoptotic Cell Death in Drug-Resistant Non-Small-Cell Lung Cancer Cells by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Based Treatments

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2014-03-0135

PREAI